Targeting NF-κB by the Cell-Permeable NEMO-Binding Domain Peptide Improves Albuminuria and Renal Lesions in an Experimental Model of Type 2 Diabetic Nephropathy
Lucas Opazo-Ríos(University of Concepción), Carmen Gómez‐Guerrero(Universidad Autónoma de Madrid)
Cited by 17
Related Papers
Fcγ Receptor Deficiency Confers Protection Against Atherosclerosis in Apolipoprotein E Knockout Mice
|Circulation Research|2006|105
Peptide-based inhibition of IκB kinase/nuclear factor-κB pathway protects against diabetes-associated nephropathy and atherosclerosis in a mouse model of type 1 diabetes
|Diabetologia|2015|43
A mutual regulatory loop between miR-155 and SOCS1 influences renal inflammation and diabetic kidney disease
|Molecular Therapy — Nucleic Acids|2023|36
Fcγ receptor activation mediates vascular inflammation and abdominal aortic aneurysm development
|Clinical and Translational Medicine|2021|25
Meta-Inflammation and De Novo Lipogenesis Markers Are Involved in Metabolic Associated Fatty Liver Disease Progression in BTBR ob/ob Mice
|International Journal of Molecular Sciences|2022|14